Randomized Sham-Controlled Trial of the Six-Month Swallowable Gas-Filled Intragastric Balloon System for Weight Loss

Obesity continues to be a significant medical problem in the United States, with a prevalence of 37.7% and an increase in overall obesity rates in women from 2005 to 2014 [1]. Multiple etiologies are likely contributing to the increasing prevalence of obesity, including lack of treatment options that are acceptable to patients. Recently, endoscopically placed and/or removed bariatric therapies have emerged as viable treatment options. These approaches have less weight loss than bariatric surgery, but are also associated with significantly lower complication rates and are approved for use in lower BMI categories [2 –5].

Source: Surgery for Obesity and Related Diseases - September 28, 2018 Category: Surgery Authors: Shelby Sullivan, James Swain, George Woodman, Steven Edmundowicz, Tarek Hassanein, Vafa Shayani, John C. Fang, Mark Noar, George Eid, Wayne J. English, Nabil Tariq, Michael Larsen, Sreenivasa S. Jonnalagadda, Dennis S. Riff, Jaime Ponce, Dayna Early, Eric Tags: Original articles Source Type: research